$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
易瑞沙国内获批上市了吗?
2025-10-19 11:44:20
Check Details
肺癌治疗用药——吉非替尼
2025-10-19 11:44:20
Check Details
易瑞沙治疗肺癌患者的疗效如何呢?
2025-10-19 11:44:20
Check Details
易瑞沙的适应症有哪些呢?
2025-10-19 11:44:20
Check Details
易瑞沙目前已知获批适应症有哪些?
2025-10-19 11:44:20
Check Details
易瑞沙对肺癌有效吗?
2025-10-19 11:44:20
Check Details
易瑞沙获批的适应症有什么?
2025-10-19 11:44:20
Check Details
易瑞沙的用法和用量
2025-10-19 11:44:20
Check Details
用易瑞沙要注意什么呢?
2025-10-19 11:44:20
Check Details
易瑞沙国内售价多少呢?
2025-10-19 11:44:20
Check Details
敏感复发小细胞肺癌:卡铂联合依托泊苷可作为合理的二线化疗选择
2025-10-19 11:44:20
Check Details
中国的拉罗替尼效果怎么样
2025-10-19 11:44:20
Check Details
1
2
...
3568
3569
3570
3571
3572
3573
3574
...
4153
4154
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Complete Guide to Dosage and Dose Adjustment of Entrectinib
2
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer
3
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment
4
Tepotinib and Osimertinib: Current Status and Clinical Positioning of Combination Therapy in Non-Small Cell Lung Cancer
5
Tumor Shrinkage Effect and Core Therapeutic Value of Pazopanib
6
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
7
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
8
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
9
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
10
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
11
Cemiplimab (Libtayo) Drug Information
12
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer